Vectus Biosystems Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vectus Biosystems Ltd with three other companies in this sector in AUSTRALIA : PYC Therapeutics Ltd (2020 sales of 62,500.00 Australian Dollars [US$48,188.13 ] of which 100% was Discovery and development of novel), Cynata Therapeutics Ltd (65,951.00 Australian Dollars [US$50,848.88 ] ), and Kazia Therapeutics Ltd (65,905.00 Australian Dollars [US$50,813.41 ] of which 100% was Pharmacetical research and development b).

Sales Analysis. Sales were up sharply during the second fiscal quarter of 2021 versus the previous year's second quarter. During the second fiscal quarter of 2021, sales at Vectus Biosystems Ltd totalled A$50,292.00 . This is an increase of 22,969.7% from the A$218.00 in sales at the company during the second quarter of 2020. Sales increased substantially in 2020: During the year ended June of 2020, sales at Vectus Biosystems Ltd were A$51,186.00 (US$39.46 thousand). This is an increase of 23,166.4% versus 2019, when the company's sales were A$220.00.